Guardant Health Insider Sells $355K in Shares

Terilyn Monroe, a Guardant Health insider, sold over 3,800 shares of the company's stock.

Apr. 7, 2026 at 10:10pm

Got story updates? Submit your updates here. ›

A close-up of complex financial machinery and instruments, conveying the tangible, industrial nature of the banking industry without using literal currency or charts.An insider's sale of over $350,000 in Guardant Health shares raises questions about the company's future prospects.Redwood City Today

Guardant Health, Inc. (NASDAQ:GH) insider Terilyn Monroe sold 3,832 shares of the company's stock on Monday, April 6th. The shares were sold at an average price of $92.68, for a total transaction value of $355,149.76. Following the sale, Monroe now owns 20,990 shares in the company, valued at $1,945,353.20.

Why it matters

Insider trading activity can provide insights into a company's performance and future prospects. The sale of over $350,000 worth of shares by a Guardant Health insider may signal potential concerns or a shift in the company's outlook.

The details

The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, which allows insiders to sell shares on a scheduled basis to avoid allegations of insider trading. Guardant Health is a precision oncology company that develops blood-based cancer diagnostics.

  • The shares were sold on Monday, April 6th, 2026.

The players

Terilyn Monroe

A Guardant Health insider who sold over 3,800 shares of the company's stock.

Guardant Health, Inc.

A precision oncology company that develops blood-based cancer diagnostics.

Got photos? Submit your photos here. ›

The takeaway

This insider sale could indicate potential concerns about Guardant Health's future performance or a shift in the company's outlook, though the transaction was executed under a pre-arranged trading plan.